Surface- and nonsurface-dependent in vitro effects of bone substitutes on cell viability

Clinical Oral Investigations

Volumn 13, Issue 2, 2009, Pages 149-155

  Herten, M ^a   Rothamel, Daniel ^b   Schwarz, F ^a   Friesen, K ^a   Koegler, G ^a   Becker, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bone marrow mesenchymal cells; Bone substitute material; Cell viability; Osteoblasts; U937 cells

Indexed keywords

ARTICLE; BONE MARROW CELL; BONE PROSTHESIS; CELL CULTURE; CELL STRAIN U937; CELL SURVIVAL; DRUG EFFECT; HUMAN; MESENCHYMAL STEM CELL; OSTEOBLAST; SURFACE PROPERTY;

BONE MARROW CELLS; BONE SUBSTITUTES; CELL SURVIVAL; CELLS, CULTURED; HUMANS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; SURFACE PROPERTIES; U937 CELLS;

EID: 67649411968     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-008-0214-8     Document Type: Article

References (34)

1. Acil Y, Springer IN, Broek V, Terheyden H, Jepsen S (2002) Effects of bone morphogenetic protein-7 stimulation on osteoblasts cultured on different biomaterials. J Cell Biochem 86:90-98
2. Araujo MG, Sonohara M, Hayacibara R, Cardaropoli G, Lindhe J (2002) Lateral ridge augmentation by the use of grafts comprised of autologous bone or a biomaterial. An experiment in the dog. J Clin Periodontol 29:1122-1131
3. Aybar B, Bilir A, Akcakaya H, Ceyhan T (2004) Effects of tricalcium phosphate bone graft materials on primary cultures of osteoblast cells in vitro. Clin Oral Implants Res 15:119-125
4. Berger TG, Feuerstein B, Strasser E, Hirsch U, Schreiner D, Schuler G, Schuler-Thurner B (2002) Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. J Immunol Methods 268:131-140
5. Betz RR (2002) Limitations of autograft and allograft: New synthetic solutions. Orthopedics 25:s561-570
6. Blottiere HM, Daculsi G, Anegon I, Pouezat JA, Nelson PN, Passuti N (1995) Utilization of activated U937 monocytic cells as a model to evaluate biocompatibility and biodegradation of synthetic calcium phosphate. Biomaterials 16:497-503
7. Busenlechner D, Tangl S, Mair B, Fugger G, Gruber R, Redl H, Watzek G (2008) Simultaneous in vivo comparison of bone substitutes in a guided bone regeneration model. Biomaterials 29:3195-3200
8. Chiriac G, Herten M, Schwarz F, Rothamel D, Becker J (2005) Autogenous bone chips: Influence of a new piezoelectric device (Piezosurgery) on chip morphology, cell viability and differentiation. J Clin Periodontol 32:994-999
9. Cimpan MR, Cressey LI, Skaug N, Halstensen A, Lie SA, Gjertsen BT, Matre R (2000) Patterns of cell death induced by eluates from denture base acrylic resins in U-937 human monoblastoid cells. Eur J Oral Sci 108:59-69
10. Clavero J, Lundgren S (2003) Ramus or chin grafts for maxillary sinus inlay and local onlay augmentation: Comparison of donor site morbidity and complications. Clin Implant Dent Relat Res 5:154-160
11. Cornell CN (1999) Osteoconductive materials and their role as substitutes for autogenous bone grafts. Orthop Clin North Am 30:591-598
12. Deligianni D, Korovessis P, Porte-Derrieu MC, Amedee J (2005) Fibronectin preadsorbed on hydroxyapatite together with rough surface structure increases osteoblasts' adhesion "in vitro": The theoretical usefulness of fibronectin preadsorption on hydroxyapatite to increase permanent stability and longevity in spine implants. J Spinal Disord Tech 18:257-262
13. Deligianni DD, Katsala ND, Koutsoukos PG, Missirlis YF (2001) Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. Biomaterials 22:87-96
14. Huber FX, Belyaev O, Hillmeier J, Kock HJ, Huber C, Meeder PJ, Berger I (2006) First histological observations on the incorporation of a novel nanocrystalline hydroxyapatite paste OSTIM in human cancellous bone. BMC Musculoskelet Disord 7:50
15. Hurzeler MB, Kirsch A, Ackermann KL, Quinones CR (1996) Reconstruction of the severely resorbed maxilla with dental implants in the augmented maxillary sinus: A 5-year clinical investigation. Int J Oral Maxillofac Implants 11:466-475
16. Khan SN, Cammisa FP Jr., Sandhu HS, Diwan AD, Girardi FP, Lane JM (2005) The biology of bone grafting. J Am Acad Orthop Surg 13:77-86
17. Kogler G, Capdeville AB, Hauch M, Bruster HT, Gobel U, Wernet P, Burdach S (1990) High efficiency of a new immunological magnetic cell sorting method for T cell depletion of human bone marrow. Bone Marrow Transplant 6:163-168
18. Kubler A, Neugebauer J, Oh JH, Scheer M, Zoller JE (2004) Growth and proliferation of human osteoblasts on different bone graft substitutes: an in vitro study. Implant Dent 13:171-179
19. Logeart-Avramoglou D, Anagnostou F, Bizios R, Petite H (2005) Engineering bone: Challenges and obstacles. J Cell Mol Med 9:72-84
20. Mayr-Wohlfart U, Fiedler J, Gunther KP, Puhl W, Kessler S (2001) Proliferation and differentiation rates of a human osteoblast-like cell line (SaOS-2) in contact with different bone substitute materials. J Biomed Mater Res 57:132-139
21. Nkenke E, Radespiel-Troger M, Wiltfang J, Schultze-Mosgau S, Winkler G, Neukam FW (2002) Morbidity of harvesting of retromolar bone grafts: A prospective study. Clin Oral Implants Res 13:514-521
22. Oreffo RO, Kusec V, Romberg S, Triffitt JT (1999) Human bone marrow osteoprogenitors express estrogen receptor-alpha and bone morphogenetic proteins 2 and 4 mRNA during osteoblastic differentiation. J Cell Biochem 75:382-392
23. Ortega-Munoz M, Morales-Sanfrutos J, Perez-Balderas F, Hernandez-Mateo F, Giron-Gonzalez MD, Sevillano-Tripero N, Salto-Gonzalez R, Santoyo-Gonzalez F (2007) Click multivalent neoglycoconjugates as synthetic activators in cell adhesion and stimulation of monocyte/ machrophage cell lines. Org Biomol Chem 5:2291-2301
24. Piattelli M, Favero GA, Scarano A, Orsini G, Piattelli A (1999) Bone reactions to anorganic bovine bone (Bio-Oss) used in sinus augmentation procedures: A histologic long-term report of 20 cases in humans. Int J Oral Maxillofac Implants 14:835-840
25. Rothamel D, Schwarz F, Herten M, Engelhardt E, Donath K, Kuehn P, Becker J (2008) Dimensional ridge alterations following socket preservation using a nanocrystalline hydroxyapatite paste. A histomorphometrical study in dogs. J Oral Maxillofac Surg 37: 741-747
26. Schlegel KA, Fichtner G, Schultze-Mosgau S, Wiltfang J (2003) Histologic findings in sinus augmentation with autogenous bone chips versus a bovine bone substitute. Int J Oral Maxiofac Implants 18:53-58
27. Seibel MJ (2000) Molecular markers of bone turnover: Biochemical, technical and analytical aspects. Osteoporos Int 11:18-29
28. Stockbauer P, Malaskova V, Soucek J, Chudomel V (1983) Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies. Neoplasma 30:257-272
29. Strietzel FP, Reichart PA, Graf HL (2007) Lateral alveolar ridge augmentation using a synthetic nano-crystalline hydroxyapatite bone substitution material (Ostim): Preliminary clinical and histological results. Clin Oral Implants Res 18:743-751
30. Trentz OA, Platz A, Helmy N, Trentz O (1998) Response of osteoblast cultures to titanium, steel and hydroxyapatite implants. Swiss Surg 203-209
31. Van Belle H (1972) Kinetics and inhibition of alkaline phosphatases from canine tissues. Biochim Biophys Acta 289:158-168
32. Wiedmann-Al-Ahmad M, Gutwald R, Gellrich NC, Hubner U, Schmelzeisen R (2005) Search for ideal biomaterials to cultivate human osteoblast-like cells for reconstructive surgery. J Mater Sci Mater Med 16:57-66
33. Yildirim M, Spiekermann H, Handt S, Edelhoff D (2001) Maxillary sinus augmentation with the xenograft Bio-Oss and autogenous intraoral bone for qualitative improvement of the implant site: A histologic and histomorphometric clinical study in humans. Int J Oral Maxillofac Implants 16:23-33
34. Zijderveld SA, Zerbo IR, van den Bergh JP, Schulten EA, ten Bruggenkate CM (2005) Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. Int J Oral Maxillofac Implants 20:432-440